Kui Kai Lau
- Health Informatics top 2%
- Neurology top 2%
- Intracerebral and Subarachnoid Hemorrhage Research 21
- Internal Medicine top 2%
-
- Cardiovascular Health and Disease Prevention 13
- Atrial Fibrillation Management and Outcomes 12
- Blood Pressure and Hypertension Studies 11
- Epidemiology top 2%
- Acute Ischemic Stroke Management 38
- Hepatitis B Virus Studies 12
-
- Cerebrovascular and Carotid Artery Diseases 20
-
- Hepatitis C virus research 10
Kui Kai Lau
126 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 127
- Health Informatics 82
- Neurology 744
- Internal Medicine 166
- Cardiology and Cardiovascular Medicine 877
- Epidemiology 1.0k
Countries citing papers authored by Kui Kai Lau
This map shows the geographic impact of Kui Kai Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Kai Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Kai Lau more than expected).
Fields of papers citing papers by Kui Kai Lau
This network shows the impact of papers produced by Kui Kai Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Kai Lau. The network helps show where Kui Kai Lau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kui Kai Lau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 22 | |
| 10 | 2023 | 103 | |
| 11 | 2023 | 32 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 19 | |
| 15 | 2022 | 3 | |
| 16 | 2021 | 4 | |
| 17 | 2021 | 20 | |
| 18 | 2021 | 7 | |
| 19 | 2020 | 8 | |
| 20 | Employment among multiple sclerosis patients in Hong Kong | 2016 | 3 |
About Kui Kai Lau
Kui Kai Lau is a scholar working on Neurology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 139 papers that have together received 3.0k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (38 papers), Intracerebral and Subarachnoid Hemorrhage Research (21 papers), Cerebrovascular and Carotid Artery Diseases (20 papers), Cardiovascular Health and Disease Prevention (13 papers), Atrial Fibrillation Management and Outcomes (12 papers), Hepatitis B Virus Studies (12 papers), Blood Pressure and Hypertension Studies (11 papers) and Hepatitis C virus research (10 papers). The work is most often cited by research in Health Informatics (82 citations), Neurology (744 citations) and Internal Medicine (166 citations). Kui Kai Lau has collaborated with scholars based in Hong Kong, China and United Kingdom. Frequent co-authors include Hung‐Fat Tse, Chung‐Wah Siu, Linxin Li, Peter M. Rothwell, Wilhelm Küker, Yap‐Hang Chan, Henry Ka‐Fung Mak, Kai‐Hang Yiu, Kay Cheong Teo and Raymond Tak Fai Cheung. Their work appears in journals such as Stroke, Cardiovascular Diabetology, Journal of the American Heart Association, Neurology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.